Invited Speakers

Anne Bassett, MD, Director, Clinical Genetics Research Program, Centre for Addiction and Mental Health, Professor, Dept of Psychiatry, University of Toronto; Medical Advisory Board, The International 22q11.2 Foundation, Inc.; Program Chair, The Eighth Biennial International 22q11.2 Deletion Syndrome Meeting, Toronto, Canada

Natalie Blagowidow, MD, FACOG, FACMG , Medical Director, Harvey Institute for Human Genetics, Prenatal Diagnostic Center and Clinical Cytogenetics Laboratory, Greater Baltimore Medical Center, Baltimore, MD, USA

Peggy S. Eicher, MD, Medical Director, Center for Pediatric Feeding & Swallowing Disorders, Attending Physician, Department of Pediatrics, St. Joseph’s Children’s Hospital, Paterson, NJ USA

Brenda Finucane, MS, CGC, Executive Director, Genetic Services at Elwyn, Media, PA, USA

Sixto García-Miñaúr, MD, Clinical Genetics Section, Institute for Medical and Molecular Genetics, La Paz University Hospital, Madrid, Spain

Elizabeth Goldmuntz, MD, FAAP, FACC, Department of Pediatrics, Cardiology, The Children’s Hospital of Philadelphia, Associate Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, PA, USA

Rick Guidotti, BFA, Founder and Director, Positive Exposure, New York, NY, USA

Alex Habel, MD, Emeritus Pediatrician, Great Ormond Street Hospital for Children, London, UK

Barbara Hass-Givler, MEd, BCBA, Board Certified Behavior Analyst, Education Specialist, Genetic Services at Elwyn, Media, PA, USA

Laird Jackson, MD, Professor, Genetics, Department of Obstetrics and Gynecology, Drexel University College of Medicine; Research Associate, Division of Genetics, The Children’s Hospital of Philadelphia, PA, USA

Maria Kamper, President, VCFS 22q11 Foundation, Charlton, Australia

Daniella Krijger, Founder and President, Hoezo Anders Foundation; Author of Anders; Former Member, 22q11.2 Support Network, Utrecht, The Netherlands

 

Anthony-S. LaMantia, Ph.D. Professor of Pharmacology and Physiology, Founding Director, George Washington Institute for Neuroscience, The George Washington University School of Medicine and Health Sciences, Washington DC

Anne Lawlor, Founding Member, 22q Ireland Support Group, Dublin, Republic of Ireland

Christian Marshall, PhD The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada

Donna M. McDonald-McGinn, MS, CGC, Associate Director, Clinical Genetics Center; Program Director, The “22q and You” Center, The Children’s Hospital of Philadelphia and The University of Pennsylvania School of Medicine; Conference Chair, The 2nd Biennial International 22q11.2 Deletion Syndrome Conference; Founding Board Member, The International 22q11.2 Foundation, Inc.; Secretary General, The Eighth Biennial International 22q11.2 Deletion Syndrome Meeting, Philadelphia, PA, USA

Aoy Tomita-Mitchell, PhD, Investigator, Children’s Research Institute; Associate Professor, Department of Surgery, Division of Cardiothoracic Surgery, Biotechnology and Bioengineering Center and Human and Molecular Genetics Center, Medical College of Wisconsin, MI, USA

 

Bernice Morrow, PhD, Professor, Department of Genetics, Department of Obstetrics & Gynecology and Women’s Health, and Department of Pediatrics (Cardiology), Sidney L. and Miriam K. Olson Chair in Cardiology, Director, Division of Translational Genetics, Albert Einstein College of Medicine, Bronx, NY

Edward Moss, PhD, Developmental Neuropsychologist, Malamut & Moss, PC, Bryn Mawr, PA, USA

Sólveig Óskarsdóttir, MD, PhD, The Queen Silvia Children’s Hospital; Department of Pediatrics The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden

Christina Persson, SLP, PhD, Division of Speech and Language Pathology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sweden

Peter Scambler, MD, Professor of Molecular Medicine, Molecular Medicine Unit; Department of Genes, Development and Disease; Faculty, Population of Health Sciences, UCL Institute of Child Health; 2010 Angelo DiGeorge Medal Recipient, London, UK

Tony J. Simon, PhD, MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California, Davis, USA

Brian Sommerlad, FRCS, Honorary Consultant Plastic Surgeon, Great Ormond Street Hospital for Children, London, St. Andrew’s Centre for Plastic Surgery, Broomfield Hospital, Chelmsford

Kathleen Sullivan, MD, PhD, Professor of Pediatrics; Division of Allergy Immunology, The Children’s Hospital of Philadelphia, PA, USA

Damian Heine Suñer, PhD, Molecular Genetics Laboratory, Department of Genetics, Hospital Universitari Son Espases, and University Institute of Investigations in Health Sciences (IUNICS), Palma, Spain

Ann Swillen, PhD, Professor, Center of Human Genetics, University Hospital of Gasthuisberg; Department of Human Genetics, Department of Rehabilitation Sciences, University of Leuven, Belgium

Nancy Unanue, MD, Endocrinology and Genetics Unit, Children’s Hospital Clinico San Boria Arriaran, Maternal and Child Health Research Institute, University of Chile, Clinica Las Condes, Santiago, Chile

Paul Wang, MD, FAAP, Developmental-Behavioral Pediatrician, Vice President, Clinical Development, Seaside Therapeutics, Cambridge, MA

Julie Wootton, Founder and President, Max Appeal, Wollaston Stourbridge, England; Conference Chair, The 7th Biennial International 22q11.2 Deletion Syndrome Meeting, Coventry, England